Gilead says has discounted hepatitis C drug for some health plans

(Reuters) - Gilead Sciences Inc, under fire for pricing a new hepatitis C drug at $1,000 a pill, has discount agreements with a number of health insurers, a company executive said in an interview.

via Reuters: Health News Read More Here..